André Lieber (Andre Lieber)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Endoplasmic Reticulum Stress

Multiple Myeloma

Top Venues

Cancer biology & therapy

bioRxiv : the preprint server for biology

Human gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hongjie Wang, Theo Koob, Jonathan R Fromm, Ajay Gopal, Darrick Carter, André Lieber
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer biology & therapy 25 (1) (2024)
Hongjie Wang, Theo Koob, Jonathan R Fromm, Ajay Gopal, Darrick Carter, André Lieber
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer biology & therapy 25 (1) (2024)
Stephanie C Bohaczuk, Zachary J Amador, Chang Li, Benjamin J Mallory, Elliott G Swanson, Jane Ranchalis, Mitchell R Vollger, Katherine M Munson, Tom Walsh, Morgan O Hamm, Yizi Mao, André Lieber, Andrew Ben Stergachis
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq. bioRxiv : the preprint server for biology (2024)
Hongjie Wang, Theo Koob, Jonathan R Fromm, Ajay Gopal, Darrick Carter, André Lieber
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer biology & therapy 25 (1) (2024)
Stephanie C Bohaczuk, Zachary J Amador, Chang Li, Benjamin J Mallory, Elliott G Swanson, Jane Ranchalis, Mitchell R Vollger, Katherine M Munson, Tom Walsh, Morgan O Hamm, Yizi Mao, André Lieber, Andrew Ben Stergachis
Resolving the chromatin impact of mosaic variants with targeted Fiber-seq. bioRxiv : the preprint server for biology (2024)
Hongjie Wang, Theo Koob, Jonathan R Fromm, Ajay Gopal, Darrick Carter, André Lieber
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer biology & therapy 25 (1) (2024)
Hongjie Wang, Theo Koob, Jonathan R Fromm, Ajay Gopal, Darrick Carter, André Lieber
CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells. Cancer biology & therapy 25 (1) (2024)
Hongjie Wang, Chang Li, Adebimpe O Obadan, Hannah Frizzell, Tien-Ying Hsiang, Sucheol Gil, Audrey Germond, Connie Fountain, Audrey Baldessari, Steve Roffler, Hans-Peter Kiem, Deborah H Fuller, André Lieber
In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor. Human gene therapy 33 (7-8) (2022)
Nikoletta Psatha, Aphrodite Georgakopoulou, Chang Li, Vivek Nandakumar, Grigorios Georgolopoulos, Reyes Acosta, Kiriaki Paschoudi, Jemma Nelson, Daniel Chee, Anastasia Athanasiadou, Anastasia Kouvatsi, Alister Peter William Funnell, André Lieber, Evangelia Yannaki, Thalia Papayannopoulou
Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood 138 (17) (2021)